Human GLP-1 Receptor Agonist (Semaglutide Biosimilar)
英诺赛图(InnoCyto)的 Human GLP-1 Receptor Agonist (Semaglutide Biosimilar)(克隆 Semaglutide) 为NA 抗体,靶向 GLP-1 receptor(别名 GLP1R 等),适用于流式细胞术。提供 1 mg、5 mg、20 mg 规格,目录价 ¥1,288 起,仅供科研使用(RUO)。
01产品图片

02产品简介
英诺赛图(InnoCyto)的 Human GLP-1 Receptor Agonist (Semaglutide Biosimilar)(克隆 Semaglutide) 为NA 抗体,靶向 GLP-1 receptor(别名 GLP1R 等),适用于流式细胞术。提供 1 mg、5 mg、20 mg 规格,目录价 ¥1,288 起,仅供科研使用(RUO)。
03产品介绍
规格与货号
505701 | 1 mg | ¥1,288
505702 | 5 mg | ¥3,254
505703 | 20 mg | ¥7,458
Product Details
Product Description|Semaglutide Biosimilar
Regulatory Status|RUO
Species specificity|Human
Storage Conditions|4ºC
Maximal Shelf Life|12 months
See All Formats|Clone Semaglutide
Background Information
Semaglutide is a synthetic peptide analogue of the human glucagon-like peptide-1 (GLP-1) hormone, designed to activate GLP-1 receptors with enhanced stability and a prolonged half-life compared to the native peptide. Structurally, Semaglutide is a 31-amino acid polypeptide that closely resembles endogenous GLP-1, differing by strategic amino acid substitutions and chemical modifications that improve resistance to enzymatic degradation and extend its duration of action. Its molecular weight is approximately 4.1 kilodaltons (kDa). These structural changes include the substitution of alanine with α-aminoisobutyric acid at position 8, which confers resistance to cleavage by dipeptidyl peptidase-4 (DPP-4), and the attachment of a C18 fatty diacid chain via a glutamic acid spacer at lysine 26, enabling reversible binding to albumin in circulation.
The molecular design of Semaglutide ensures a balance between receptor activation and molecular stability. The peptide adopts a helical conformation similar to native GLP-1 when bound to the GLP-1 receptor, a class B G protein-coupled receptor (GPCR). The N-terminal region interacts with the receptor’s transmembrane domain, initiating receptor activation and intracellular signaling. This activation triggers the adenylate cyclase pathway, leading to cyclic adenosine monophosphate (cAMP) accumulation, protein kinase A (PKA) activation, and modulation of downstream metabolic enzymes. Additionally, the C-terminal acylation with the long-chain fatty diacid anchors the molecule to plasma albumin, reducing renal clearance and protecting it from proteolytic degradation, significantly extending its half-life.
Functionally, Semaglutide mimics the biological activity of endogenous GLP-1, promoting sustained receptor signaling in experimental models of glucose metabolism and energy balance. Its prolonged receptor occupancy and systemic stability make it a useful model for studying GPCR kinetics, peptide–receptor binding dynamics, and the role of structural modifications in peptide pharmacology.
Data Sheets
Cat # Size Price Quantity 5057011 mg Add to Cart5057025 mg Add to Cart50570320 mg Add to Cart
04完整参数表
参数由厂商资料整理,采购前请以最终报价单与技术协议为准。
05荣誉与资质
该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。
- 营业执照未上传
- 品牌授权未上传
- 产品检测报告未上传
- 会员身份
- 收费会员
- 经营身份
- 原厂
- 成立年份
- 2020 年
- 所在地
- 上海
- 收录条目
- 1865 个
- 平台核验
- 平台代管
06品牌与供应商
InnoCyto(上海英诺赛图生物科技有限公司)致力于通过开发高质量细胞分析试剂,加速科学发现进程。公司为研究人员提供细胞层面探索所需的工具,推动免疫学、肿瘤学等多领域的研究创新。 核心团队拥有丰富的行业经验,曾参与全球头部生命科学公司的标杆项目搭建,深刻理解工业界与学术研究的前沿需求。试剂从设计之初即以精确性、一致性、高性能为核心标准,让科学家能把精力集中在最核心的研究工作上。 公司将深厚的科学积累与对品质的严格承诺相结合,力争成为全球研究人员信赖的合作伙伴。产品线覆盖经验证的一抗与二抗、同型对照、生物类似药抗体、重组蛋白、细胞因子、免疫检测试剂盒及配套试剂,并提供重组蛋白/抗体表达与标记偶联服务。
品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。
07同类条目
同一子类内的条目才具备可比性。跨子类比较参数通常没有意义。
08同品牌其他条目
上海英诺赛图 在本目录共 1865 个条目,除本条外还有:
科研在线(TeleVM). Human GLP-1 Receptor Agonist (Semaglutide Biosimilar)(505701)[EB/OL]. 产品目录, 2026-11-12. https://www.suprotek.cn/products/item/human-glp-1-receptor-agonist-semaglutide-biosimilar.html.
TeleVM. (2026, November 12). Human GLP-1 Receptor Agonist (Semaglutide Biosimilar)(505701). 产品目录. https://www.suprotek.cn/products/item/human-glp-1-receptor-agonist-semaglutide-biosimilar.html
@misc{biocsp_item_human_glp_1_receptor_agonist_semaglutide_biosimilar,
title = {Human GLP-1 Receptor Agonist (Semaglutide Biosimilar)(505701)},
author = {{科研在线}},
year = {2026},
howpublished = {产品目录},
note = {更新于 2026-11-12,产品目录},
url = {https://www.suprotek.cn/products/item/human-glp-1-receptor-agonist-semaglutide-biosimilar.html}
}
GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。
许可:CC BY-NC 4.0 · 转载注明来源